To assess the immunogenicity of the qHPV and HAV/HBV vaccine when co-administered ( Group-Co-adm ) or given one month apart ( Group-Sep ) and to measure the persistence of HPV antibodies three years post-second dose of qHPV vaccine in both study groups .